BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7739411)

  • 1. Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle.
    Bisset LR
    Med Hypotheses; 1994 Dec; 43(6):388-96. PubMed ID: 7739411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mycoplasma genitalium adhesin protein and several human class II MHC proteins exhibit sequence homology: possible ramifications for the development of autoimmunity.
    Bisset LR
    Autoimmunity; 1992; 14(2):167-8. PubMed ID: 1303682
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4 similarity to proteins of infectious agents in AIDS and their role in autoimmunity.
    Root-Bernstein RS; Dewitt SH
    Med Hypotheses; 1994 Dec; 43(6):361-71. PubMed ID: 7739408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential importance of MHC mimicry by HIV in the pathogenesis of AIDS.
    Sheikh J; Ongradi J; Austen B; Dalgleish A
    Biochem Soc Trans; 1995 Aug; 23(3):471S. PubMed ID: 8566367
    [No Abstract]   [Full Text] [Related]  

  • 5. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS and immune dysfunction. Alternative etiologic mechanisms.
    del Guercio P
    Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mycoplasmas and AIDS].
    Coronato S
    Rev Argent Microbiol; 1997; 29(3):157-66. PubMed ID: 9411491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titers of antibody to Mycoplasma in sera of patients infected with human immunodeficiency virus.
    Tully JG; Shih JW; Wang RH; Rose DL; Lo SC
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S254-8. PubMed ID: 8399925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biological bases of resistance to HIV/AIDS (the hypothesis with elements of the theory).
    Skripal IG
    Mikrobiol Z; 1995; 57(4):89-105. PubMed ID: 8548075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the HIV envelope induce a chronic graft-versus-host-like disease?
    Habeshaw J; Hounsell E; Dalgleish A
    Immunol Today; 1992 Jun; 13(6):207-10. PubMed ID: 1627248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactivity in HIV-1 infection: the role of molecular mimicry.
    Silvestris F; Williams RC; Dammacco F
    Clin Immunol Immunopathol; 1995 Jun; 75(3):197-205. PubMed ID: 7768037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross reaction. Could AIDS really be an autoimmune disease?
    Beardsley T
    Sci Am; 1991 Dec; 265(6):56-7. PubMed ID: 1754873
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy.
    Weber GF; Cantor H
    Med Hypotheses; 1993 Sep; 41(3):247-50. PubMed ID: 8259084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologies between mycoplasma adhesion peptide, CD4 and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS.
    Root-Bernstein RS; Hobbs SH
    Res Immunol; 1991 Sep; 142(7):519-23. PubMed ID: 1812547
    [No Abstract]   [Full Text] [Related]  

  • 18. GP120: target for neutralizing HIV-1 antibodies.
    Pantophlet R; Burton DR
    Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.